89 related articles for article (PubMed ID: 22242968)
1. The association between -330T/G polymorphism of interleukin 2 gene and bladder cancer.
Shen Y; Liu Y; Liu S; Zhang A
DNA Cell Biol; 2012 Jun; 31(6):983-7. PubMed ID: 22242968
[TBL] [Abstract][Full Text] [Related]
2. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
5. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
[TBL] [Abstract][Full Text] [Related]
7. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
Bid HK; Manchanda PK; Mittal RD
Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
[TBL] [Abstract][Full Text] [Related]
8. Association of cytokine gene polymorphisms in patients with tuberculosis and their household contacts.
Sivangala R; Ponnana M; Thada S; Joshi L; Ansari S; Hussain H; Valluri V; Gaddam S
Scand J Immunol; 2014 Mar; 79(3):197-205. PubMed ID: 24313289
[TBL] [Abstract][Full Text] [Related]
9. CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
Song YL; Wang L; Ren JC; Xu ZH
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173252
[TBL] [Abstract][Full Text] [Related]
10. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
[TBL] [Abstract][Full Text] [Related]
11. A new genetic variant involved in genetic susceptibility to alcoholic liver cirrhosis: -330T>G polymorphism of the interleukin-2 gene.
Marcos M; Pastor I; González-Sarmiento R; Laso FJ
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):855-9. PubMed ID: 18794598
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 gene polymorphisms and prognosis of breast cancer.
Hu XB; Ouyang LZ; Tang LL
Genet Test Mol Biomarkers; 2013 Jun; 17(6):453-7. PubMed ID: 23477313
[TBL] [Abstract][Full Text] [Related]
13. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Chen L; Cha Z; Bai J
DNA Cell Biol; 2012 Jul; 31(7):1279-84. PubMed ID: 22472080
[TBL] [Abstract][Full Text] [Related]
15. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
17. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
[TBL] [Abstract][Full Text] [Related]
18. Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.
Gu J; Tao J; Yang X; Li P; Yang X; Qin C; Cao Q; Cai H; Zhang Z; Wang M; Gu M; Lu Q; Yin C
Cancer Genet; 2014 Jun; 207(6):247-52. PubMed ID: 25150583
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between polymorphism of IL-2 -330T/G and pulmonary tuberculosis among Caucasians.
Ge H; Chen S; Zhu J
Innate Immun; 2020 Jul; 26(5):398-402. PubMed ID: 31906759
[TBL] [Abstract][Full Text] [Related]
20. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
